The promise of breakthrough drugs such as liraglutide and semaglutide to help people lose weight has been the subject of extensive media coverage in recent months, with Wegovy the latest such jab to be approved for use on the NHS for certain groups of people with obesity – although it has yet to become available.
With such drugs also available through online pharmacies by private prescription, a growing number of people have tried the jabs – including Ozempic, a medication that contains semaglutide, the same drug as Wegovy. While Ozempic is licensed for type 2 diabetes, its use in weight loss is off-label – or unapproved by regulators.
